← Back to patent-cliff list
CAS 14906-64-0
3-cyano-1-oxidopyridin-1-ium
Codes: (VII)320339-3-a
Application context (from source-drug indications)
C型尼曼匹克病Arimoclomol Citrate包涵体肌炎Arimoclomol CitrateIII 型戈谢病Arimoclomol CitrateI 型戈谢病Arimoclomol CitrateAmyotrophic lateral sclerosisArimoclomol Citrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Arimoclomol Citrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Benzophenone oxime→(R)-(-)-Glycidyl m-nitrobenzenesulfonate→N-[[(2R)-Oxiran-2-yl]methoxy]-1,1-diphenylmethanimine→Azacyclohexane→N-[(2R)-2-Hydroxy-3-(piperidin-1-yl)propoxy]-1-oxo-1lambda5-pyridine-3-carboximidoyl chloride→(2R)-1-[[(Diphenylmethylidene)amino]oxy]-3-(piperidin-1-yl)propan-2-ol→(2R)-1-(Aminooxy)-3-(piperidin-1-yl)propan-2-ol--hydrogen chloride (1/1)→3-cyano-1-oxidopyridin-1-ium→N'-[(2R)-2-Hydroxy-3-(piperidin-1-yl)propoxy]-1-oxo-1lambda5-pyridine-3-carboximidamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.